NBE-Therapeutics AG   Report issue

For profit Phase 2
Founded: Basel Switzerland (2012)
Status: Acquired by Boehringer Ingelheim (2021)

Organization Overview

First Clinical Trial
2020
NCT04441099
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

NBE-Therapeutics AG